Neocutis, a physician-dispensed skincare brand, delivers innovative skincare solutions to address key skincare concerns, including the signs of aging, discoloration, oxidative stress, skin redness, and dryness. Neocutis products were founded based on research through the Medical School at the University Hospital of Lausanne, Switzerland after research showed their patented PSP® (Processed Skin Proteins) improved wound healing. This technology was then introduced to offer a solution for anti-aging and post-procedure skincare.
As skincare research advanced, a more thorough understanding of the role of the extracellular matrix (ECM) in skin aging emerged. These new insights led to the development MPC™ (Micro Protein Complex), an anti-aging technology developed to address all five of the key components in the ECM that impact aging: Collagens I, III, VII, Elastin, and Hyaluronic Acid. MPC™ technology targets the signs of aging including firmness, skin elasticity, and fine wrinkles.
All Neocutis products work together to restore a smoother, brighter, and softer texture to the skin. Due to Neocutis’ proprietary ingredients that promote wound healing, Dr. Biesman and his staff may recommend products in this line for post-procedure skincare. All Neocutis products are formulated to be free of artificial fragrances or color additives.